In a significant move, Biocon has secured a ten-year contract in Brazil for the distribution of Pertuzumab, made possible through its colla...

The Supreme Court ruled criminal cases against companies can proceed without specific individuals named. This decision impacts corporate cr...

Prasol Chemicals has raised nearly Rs 150 crore from anchor investors ahead of its Rs 500-crore IPO, which opens on September 8. The specia...

Karnataka is seeking French investment in manufacturing and emerging sectors. Discussions were held with Roquette, bioMerieux, and Hutchins...

The exploration of citrus peels by researchers unveils valuable antioxidant and anti-inflammatory compounds. Various citrus varieties and t...

Customs officers must now manually check import documents for healthcare products. This manual verification applies even to facilitated imp...

Piyush Goyal emphasized the importance of enhancing India's pharmaceutical industry to draw in more investments. He urged for the creation ...

The introduction of eight free trade agreements heralds a new era of duty-free market access, particularly benefiting the electronics, agri...

RPG Active Pharma is acquiring Raghava Life Sciences' API and intermediates business. This strategic move aims to strengthen its integrated...

Prasol Chemicals will launch its Rs 500-crore Initial Public Offering on September 8. The company has fixed the price band at Rs 643-676 pe...

Sun Pharmaceutical Industries will offer its drugs at prices matching other developed nations. This agreement aims to make healthcare affor...

Permira, a leading global private equity firm, is ready to buy a significant stake in Cloudnine Hospitals, which places the parent company'...

Sun Pharma ranks second in US dermatology by prescriptions, with key brands including Ilumya for plaque psoriasis and Winlevi for acne. Rec...

India seeks predictable regulatory pathways in Brazil to boost pharmaceutical exports. This move aims to ensure affordable and quality medi...

Nine pharmaceutical firms reached deals with the Trump administration for lower drug prices. These agreements expand the total number of co...

Aurobindo Pharma shares rose sharply after its subsidiary Lannett Company launched the generic equivalent of Advair Diskus in the US. The i...

India seeks predictable regulations and easier market access for its pharmaceutical products. Discussions occurred at the India-Brazil Trad...